Nanoliposomal irinotecan in metastatic pancreatic cancer - Authors' reply.

Chen, Li-Tzong; Wang-Gillam, Andrea; Von Hoff, Daniel D; Bayever, Eliel; Belanger, Bruce

Chen, Li-Tzong; Wang-Gillam, Andrea; Von Hoff, Daniel D; Bayever, Eliel; Belanger, Bruce.

Afiliação

Chen LT; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan; Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan. Electronic address: leochen@nhri.org.tw.
Wang-Gillam A; Washington University School of Medicine, St Louis, MO, USA.
Von Hoff DD; TGen, Phoenix, AZ, USA; HonorHealth, Scottsdale, AZ, USA.
Bayever E; Merrimack Pharmaceuticals, Inc, Cambridge, MA, USA.
Belanger B; Merrimack Pharmaceuticals, Inc, Cambridge, MA, USA.

Lancet ; 387(10032): 1997, 2016 May 14.

Article em En | MEDLINE | ID: mdl-27203770

Assuntos

Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Carcinoma Ductal Pancreático/tratamento farmacológico; Neoplasias Pancreáticas/tratamento farmacológico; Feminino; Humanos; Masculino

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Ductal Pancreático Limite: Female / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google